Nwam LLC Astrazeneca PLC Transaction History
Nwam LLC
- $1.34 Billion
- Q3 2025
A detailed history of Nwam LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Nwam LLC holds 8,667 shares of AZN stock, worth $774,829. This represents 0.05% of its overall portfolio holdings.
Number of Shares
8,667
Previous 7,036
23.18%
Holding current value
$774,829
Previous $491,000
35.23%
% of portfolio
0.05%
Previous 0.04%
Shares
15 transactions
Others Institutions Holding AZN
# of Institutions
1,497Shares Held
500MCall Options Held
5.59MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...